-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Is It Smart To Buy Raffles Medical Group Ltd (SGX:BSL) Before It Goes Ex-Dividend?
Is It Smart To Buy Raffles Medical Group Ltd (SGX:BSL) Before It Goes Ex-Dividend?
Readers hoping to buy Raffles Medical Group Ltd (SGX:BSL) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day before a company's record date, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, Raffles Medical Group investors that purchase the stock on or after the 9th of May will not receive the dividend, which will be paid on the 19th of May.
The upcoming dividend for Raffles Medical Group will put a total of S$0.028 per share in shareholders' pockets, up from last year's total dividends of S$0.018. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
Check out our latest analysis for Raffles Medical Group
If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Fortunately Raffles Medical Group's payout ratio is modest, at just 40% of profit. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Thankfully its dividend payments took up just 35% of the free cash flow it generated, which is a comfortable payout ratio.
It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
SGX:BSL Historic Dividend May 4th 2022Have Earnings And Dividends Been Growing?
Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. This is why it's a relief to see Raffles Medical Group earnings per share are up 2.3% per annum over the last five years. Recent growth has not been impressive. However, companies that see their growth slow can often choose to pay out a greater percentage of earnings to shareholders, which could see the dividend continue to rise.
Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Raffles Medical Group has delivered an average of 4.4% per year annual increase in its dividend, based on the past 10 years of dividend payments. It's encouraging to see the company lifting dividends while earnings are growing, suggesting at least some corporate interest in rewarding shareholders.
The Bottom Line
Is Raffles Medical Group worth buying for its dividend? Earnings per share have been growing moderately, and Raffles Medical Group is paying out less than half its earnings and cash flow as dividends, which is an attractive combination as it suggests the company is investing in growth. It might be nice to see earnings growing faster, but Raffles Medical Group is being conservative with its dividend payouts and could still perform reasonably over the long run. Raffles Medical Group looks solid on this analysis overall, and we'd definitely consider investigating it more closely.
Ever wonder what the future holds for Raffles Medical Group? See what the 10 analysts we track are forecasting, with this visualisation of its historical and future estimated earnings and cash flow
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Readers hoping to buy Raffles Medical Group Ltd (SGX:BSL) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day before a company's record date, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, Raffles Medical Group investors that purchase the stock on or after the 9th of May will not receive the dividend, which will be paid on the 19th of May.
希望购买的读者莱佛士医疗集团有限公司(SGX:BSL)的股息将需要很快采取行动,因为该股即将进行不含股息的交易。除息日期是公司记录日期的前一个工作日,也就是公司决定哪些股东有权获得股息的日期。除息日期很重要,因为股票的任何交易都需要在记录日期之前结算,才有资格获得股息。因此,在5月9日或之后购买该股票的莱佛士医疗集团投资者将不会收到股息,股息将在5月19日支付。
The upcoming dividend for Raffles Medical Group will put a total of S$0.028 per share in shareholders' pockets, up from last year's total dividends of S$0.018. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
莱佛士医疗集团即将到来的股息将使股东的口袋里总计每股0.028新元,高于去年0.018新元的总股息。股息是长期持有者投资回报的主要贡献者,但前提是继续支付股息。这就是为什么我们应该总是检查股息支付是否看起来可持续,以及公司是否在增长。
Check out our latest analysis for Raffles Medical Group
查看我们对莱佛士医疗集团的最新分析
If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Fortunately Raffles Medical Group's payout ratio is modest, at just 40% of profit. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Thankfully its dividend payments took up just 35% of the free cash flow it generated, which is a comfortable payout ratio.
如果一家公司支付的股息超过了它赚取的股息,那么股息可能会变得不可持续--这几乎不是一个理想的情况。幸运的是,莱佛士医疗集团的派息率不高,仅占利润的40%。这就是说,即使是高利润的公司有时也可能无法产生足够的现金来支付股息,这就是为什么我们应该总是检查股息是否由现金流覆盖。值得庆幸的是,它的股息支付仅占其产生的自由现金流的35%,这是一个令人满意的派息率。
It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.
看到利润和现金流都涵盖了股息,这是令人鼓舞的。这通常表明,只要收益不会急剧下降,股息是可持续的。
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
点击此处查看该公司的派息率,以及分析师对其未来股息的估计。
Have Earnings And Dividends Been Growing?
盈利和股息一直在增长吗?
Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. This is why it's a relief to see Raffles Medical Group earnings per share are up 2.3% per annum over the last five years. Recent growth has not been impressive. However, companies that see their growth slow can often choose to pay out a greater percentage of earnings to shareholders, which could see the dividend continue to rise.
产生可持续收益增长的公司的股票往往是最好的股息前景,因为当收益上升时,提高股息更容易。如果业务进入低迷,股息被削减,该公司的价值可能会急剧缩水。这就是为什么看到莱佛士医疗集团的每股收益在过去五年里以每年2.3%的速度增长,这让人松了一口气。最近的增长并不令人印象深刻。然而,增长放缓的公司通常可以选择向股东支付更高比例的收益,这可能会看到股息继续上升。
Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Raffles Medical Group has delivered an average of 4.4% per year annual increase in its dividend, based on the past 10 years of dividend payments. It's encouraging to see the company lifting dividends while earnings are growing, suggesting at least some corporate interest in rewarding shareholders.
衡量一家公司股息前景的另一个关键方法是衡量其历史股息增长率。根据过去10年的股息支付,莱佛士医疗集团的股息平均每年增加4.4%。看到该公司在盈利增长的同时提高股息,这是令人鼓舞的,这表明至少有一些公司有兴趣回报股东。
The Bottom Line
底线
Is Raffles Medical Group worth buying for its dividend? Earnings per share have been growing moderately, and Raffles Medical Group is paying out less than half its earnings and cash flow as dividends, which is an attractive combination as it suggests the company is investing in growth. It might be nice to see earnings growing faster, but Raffles Medical Group is being conservative with its dividend payouts and could still perform reasonably over the long run. Raffles Medical Group looks solid on this analysis overall, and we'd definitely consider investigating it more closely.
莱佛士医疗集团值得为其股息而收购吗?每股收益一直在温和增长,莱佛士医疗集团只支付了不到一半的收益和现金流作为股息,这是一个有吸引力的组合,因为它表明该公司正在投资于增长。看到收益增长更快可能是件好事,但莱佛士医疗集团对股息支付持保守态度,长期而言仍有可能表现合理。莱佛士医疗集团总体上看起来对这一分析是可靠的,我们肯定会考虑更仔细地调查它。
Ever wonder what the future holds for Raffles Medical Group? See what the 10 analysts we track are forecasting, with this visualisation of its historical and future estimated earnings and cash flow
想过莱佛士医疗集团的未来会是什么样子吗?查看我们跟踪的10位分析师对其历史和未来估计收益和现金流的可视化预测
A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.
一个常见的投资错误是购买你看到的第一只有趣的股票。在这里,你可以找到高收益红利股票的完整清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有什么反馈吗?担心内容吗?保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
这篇由《华尔街日报》撰写的文章本质上是笼统的。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。简单地说,华尔街在提到的任何股票中都没有头寸。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧